NASDAQ: NPCE
Neuropace Inc Stock Ownership - Who owns Neuropace?

Insider buying vs selling

Have Neuropace Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-04-22237$10.94
$2.59kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-04-22237$10.94
$2.59kSell
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-03-031,337$11.81
$15.79kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-03-031,337$11.81
$15.79kSell
Joel BeckerCHIEF EXECUTIVE OFFICER2025-02-274,506$12.56
$56.60kSell
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-02-271,430$12.56
$17.96kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-02-271,430$12.56
$17.96kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-02-2178,334$13.72
$1.07MSell
Kck Ltd10% Owner2025-02-205,270,845$9.40
$49.55MSell
Rebecca KuhnChief Financial Officer2025-02-203,405$14.23
$48.45kSell

1 of 7

NPCE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NPCE insiders and whales buy or sell their stock.

NPCE Shareholders

What type of owners hold Neuropace Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Greg Shaw Garfield17.36%5,653,237$65.69MInsider
Kck Ltd16.19%5,270,845$61.25MInstitution
Accelmed Partners II LP13.61%4,432,948$51.51MInsider
URI Geiger13.61%4,432,948$51.51MInsider
Evan Norton12.42%4,042,657$46.98MInsider
Orbimed Advisors LLC11.18%3,641,335$42.31MInsider
Orbimed Advisors LLC10.46%3,406,335$39.58MInstitution
Morgan Stanley7.65%2,491,830$28.96MInstitution
Soleus Capital Management LP7.47%2,433,168$28.27MInstitution
Kent Lake Pr LLC4.55%1,482,555$17.23MInstitution

1 of 3

NPCE vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NPCE46.44%53.56%Net SellingNet Selling
CLPT27.52%25.86%Net SellingNet Selling
DCTH39.34%60.66%Net Buying
VREX97.44%1.66%Net SellingNet Selling
TMCI46.73%53.27%Net BuyingNet Buying

Neuropace Stock Ownership FAQ

Who owns Neuropace?

Neuropace (NASDAQ: NPCE) is owned by 64.09% institutional shareholders, 73.91% Neuropace insiders, and 0.00% retail investors. Greg Shaw Garfield is the largest individual Neuropace shareholder, owning 5.65M shares representing 17.36% of the company. Greg Shaw Garfield's Neuropace shares are currently valued at $67.73M.

If you're new to stock investing, here's how to buy Neuropace stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.